Artgen Biotech PJSC Balance Sheet

Financials in millions RUB. Fiscal year is January - December.

Millions RUB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	344.49	503.35	544.94	201.66	193.29	107.39
Trading Asset Securities	62.39	35.11	27.39	25.4	0.51	0.51
Cash & Short-Term Investments	406.88	538.46	572.33	227.06	193.8	107.9
Cash Growth	3.03%	-5.92%	152.07%	17.16%	79.61%	-39.49%
Accounts Receivable	113.47	67.3	81.83	67.86	83.2	90.18
Other Receivables	77.68	52.33	72.58	61.69	23.92	41.98
Receivables	241.2	189.6	205.38	185.11	131.76	151.46
Inventory	262.96	246.84	226.31	223.87	245.79	233.54
Other Current Assets	139.74	97.94	113.22	53.74	86.71	83.04
Total Current Assets	1,051	1,073	1,117	689.77	658.06	575.93
Property, Plant & Equipment	396.69	376.86	315.87	280.51	285	330.25
Long-Term Investments	92.37	96.91	161.33	193.34	120.62	54.35
Other Intangible Assets	336.82	347.92	174.9	150.1	128.6	116.93
Long-Term Deferred Tax Assets	124.55	115.23	90.83	83.03	86.12	76.03
Long-Term Deferred Charges	529.85	510.21	631.35	586.62	414.09	342.11
Total Assets	2,750	2,671	2,544	2,045	1,737	1,512
Accounts Payable	48.27	54.92	53.41	33.87	35.94	35.38
Short-Term Debt	-	-	0.73	0.73	0.2	0.19
Current Portion of Long-Term Debt	26.88	87.71	219.72	106.44	-	177.77
Current Portion of Leases	26.01	25.17	19.53	11.69	8.89	9.91
Current Income Taxes Payable	22.07	15	24.84	24.57	14.61	10.7
Other Current Liabilities	253.07	286.11	243.16	218.28	312.52	322.18
Total Current Liabilities	376.29	468.91	561.4	395.57	372.15	556.13
Long-Term Debt	504.76	480.5	427.2	601.38	494.23	175
Long-Term Leases	128.17	144.28	119.77	111.36	113.82	125.59
Other Long-Term Liabilities	511.12	504.13	460.96	366	296.49	240.38
Total Liabilities	1,520	1,598	1,569	1,474	1,277	1,097
Common Stock	9.27	9.27	9.27	9.27	8.5	7.5
Additional Paid-In Capital	638.87	626.58	625.13	612.1	567.43	151.93
Retained Earnings	481	365.43	241.53	146.45	94.13	69.42
Treasury Stock	-495.37	-499.39	-421.99	-447.85	-446.98	-34.97
Comprehensive Income & Other	-94.51	-94.51	-30.06	21.07	11.7	0.38
Total Common Equity	539.25	407.37	423.87	341.04	234.78	194.26
Minority Interest	690.18	666.25	550.86	229.22	225.78	220.74
Shareholders' Equity	1,229	1,074	974.73	570.26	460.56	415
Total Liabilities & Equity	2,750	2,671	2,544	2,045	1,737	1,512
Total Debt	685.82	737.65	786.96	831.6	617.13	488.46
Net Cash (Debt)	-278.94	-199.2	-214.62	-604.55	-423.33	-380.56
Net Cash Per Share	-3.00	-2.15	-2.32	-6.96	-5.29	-5.07
Filing Date Shares Outstanding	73.94	73.76	75.15	81.61	85	75
Total Common Shares Outstanding	73.94	73.76	75.15	81.61	85	75
Working Capital	674.48	603.94	555.84	294.2	285.9	19.81
Book Value Per Share	7.29	5.52	5.64	4.18	2.76	2.59
Tangible Book Value	202.43	59.45	248.97	190.94	106.18	77.33
Tangible Book Value Per Share	2.74	0.81	3.31	2.34	1.25	1.03
Buildings	61.87	63.02	67.06	49.65	97.89	94.08
Machinery	432.91	419.13	375.42	353.72	336.45	325.07
Construction In Progress	55.32	16.15	-	-	0.05	0.9

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.